ADIL   $1.0  -2.91% Market Closed After Close 1.0 0.0

Adial Pharmaceuticals Inc
Total Cash 3.29M
totalCashPerShare 0.513
EBITDA -7.27M
Total Debt 0.00
quickRatio 4.894
currentRatio 5.691
Total Revenue
debtToEquity
Revenue/Share
ROA -1.04181
ROE -3.20963
grossProfits
freeCashflow -2.99M
operatingCashflow -6.39M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 3.18M
forwardPE -0.75939846
floatShares 6.29M
sharesOutstanding 6.41M
sharesShort 51.17K
sharesShortPriorMonth 146.73K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.04%
Short Ratio help_outline 0.67%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.996
Price To Book help_outline 1.01
earningsQuarterlyGrowth
netIncomeToCommon -12.19M
trailingEps -3.99%
forwardEps -1.33%
enterpriseToEbitda -0.44
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 15
lastUpdated Nov. 7, 2024, 2:45 a.m.